Financials
- Market Capitalization 5.24 M
- Employee 13
- Founded 1981
- CEO Eric A. Adams
- Website www.inmedpharma.com
- Headquarter British Columbia, Canada
- FIGI BBG000BT4589
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4968 | SNGX Soligenix, Inc. - Common Stock | 0.36 USD | +2.86% | -7.69% | -16.28% | -68.14% | 5.34 M USD | ||
| 4969 | DRMA Dermata Therapeutics, Inc. - Common Stock | 1.32 USD | -2.22% | -5.71% | +10.00% | -7.69% | 5.31 M USD | ||
| 4973 | MLEC Moolec Science SA - Ordinary Shares | 7.16 USD | -9.14% | -5.17% | -3.89% | +87.43% | 5.20 M USD | ||
| 4974 | GNPX Genprex, Inc. - Common Stock | 0.49 USD | -9.26% | -18.33% | -19.67% | -73.80% | 5.19 M USD |
Frequently asked questions about InMed Pharmaceuticals Inc. - Common Shares
What is the InMed Pharmaceuticals Inc. - Common Shares stock price today?
The current price of InMed Pharmaceuticals Inc. - Common Shares (INM) is 1.58. Over the past 24 hours, the stock has changed by +0.64%. Follow the INM chart for real-time price dynamics.
What is the stock ticker of InMed Pharmaceuticals Inc. - Common Shares?
InMed Pharmaceuticals Inc. - Common Shares trades under the ticker INM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is InMed Pharmaceuticals Inc. - Common Shares stock going up?
INM has changed by -4.24% over the last week, +2.60% over the last month, and -47.16% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was InMed Pharmaceuticals Inc. - Common Shares net income for the last quarter?
InMed Pharmaceuticals Inc. - Common Shares reported net income of -2.97 M for the last quarter. The previous quarter showed -2.03 M, which means net income changed by -46.25%.
How many employees does InMed Pharmaceuticals Inc. - Common Shares have?
As of the latest available data, InMed Pharmaceuticals Inc. - Common Shares has 13 employees. Workforce size can provide additional context about the company's scale and operations.
What is InMed Pharmaceuticals Inc. - Common Shares EBITDA?
InMed Pharmaceuticals Inc. - Common Shares EBITDA is -2.81 M, and its EBITDA margin is 12.14 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy InMed Pharmaceuticals Inc. - Common Shares stock?
You can buy InMed Pharmaceuticals Inc. - Common Shares (INM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in InMed Pharmaceuticals Inc. - Common Shares stock?
Investing in InMed Pharmaceuticals Inc. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INM chart and related analysis on metatrader.com as part of your research.